Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 855
Filtrar
1.
J Immunol ; 211(5): 804-815, 2023 09 01.
Artículo en Inglés | MEDLINE | ID: mdl-37436030

RESUMEN

Because of the growing numbers of immunocompromised patients, the incidence of life-threatening fungal infections caused by Candida albicans and Aspergillus fumigatus is increasing. We have recently identified enolase 1 (Eno1) from A. fumigatus as an immune evasion protein. Eno1 is a fungal moonlighting protein that mediates adhesion and invasion of human cells and also immune evasion through complement inactivation. We now show that soluble Eno1 has immunostimulatory activity. We observed that Eno1 from both C. albicans and A. fumigatus directly binds to the surface of lymphocytes, preferentially human and mouse B cells. Functionally, Eno1 upregulated CD86 expression on B cells and induced proliferation. Although the receptor for fungal Eno1 on B lymphocytes is still unknown, the comparison of B cells from wild-type and MyD88-deficient mice showed that B cell activation by Eno1 required MyD88 signaling. With respect to infection biology, we noted that mouse B cells stimulated by Eno1 secreted IgM and IgG2b. These Igs bound C. albicans hyphae in vitro, suggesting that Eno1-induced Ab secretion might contribute to protection from invasive fungal disease in vivo. Eno1 also triggered the release of proinflammatory cytokines from monocytes, particularly IL-6, which is a potent activator of B cells. Together, our data shed new light on the role of secreted Eno1 in infections with C. albicans and A. fumigatus. Eno1 secretion by these pathogenic microbes appears to be a double-edged sword by supporting fungal pathogenicity while triggering (antifungal) immunity.


Asunto(s)
Aspergillus fumigatus , Candida albicans , Fosfopiruvato Hidratasa , Animales , Humanos , Ratones , Aspergillus fumigatus/enzimología , Aspergillus fumigatus/metabolismo , Candida albicans/enzimología , Candida albicans/metabolismo , Proteínas Fúngicas/genética , Proteínas Fúngicas/metabolismo , Monocitos/metabolismo , Monocitos/microbiología , Factor 88 de Diferenciación Mieloide/genética , Factor 88 de Diferenciación Mieloide/metabolismo , Fosfopiruvato Hidratasa/metabolismo , Linfocitos B/metabolismo , Linfocitos B/microbiología
2.
Sci Rep ; 12(1): 251, 2022 01 07.
Artículo en Inglés | MEDLINE | ID: mdl-34997046

RESUMEN

Shigellosis is characterized as diarrheal disease that causes a high mortality rate especially in children, elderly and immunocompromised patients. More recently, the World Health Organization advised safe vaccine designing against shigellosis due to the emergence of Shigella dysenteriae resistant strains. Therefore, the aim of this study is to identify novel drug targets as well as the design of the potential vaccine candidates and chimeric vaccine models against Shigella dysenteriae. A computational based Reverse Vaccinology along with subtractive genomics analysis is one of the robust approaches used for the prioritization of drug targets and vaccine candidates through direct screening of genome sequence assemblies. Herein, a successfully designed peptide-based novel highly antigenic chimeric vaccine candidate against Shigella dysenteriae sd197 strain is proposed. The study resulted in six epitopes from outer membrane WP_000188255.1 (Fe (3+) dicitrate transport protein FecA) that ultimately leads to the construction of twelve vaccine models. Moreover, V9 construct was found to be highly immunogenic, non-toxic, non-allergenic, highly antigenic, and most stable in terms of molecular docking and simulation studies against six HLAs and TLRS/MD complex. So far, this protein and multiepitope have never been characterized as vaccine targets against Shigella dysenteriae. The current study proposed that V9 could be a significant vaccine candidate against shigellosis and to ascertain that further experiments may be applied by the scientific community focused on shigellosis.


Asunto(s)
Antibacterianos/farmacología , Vacunas Bacterianas/farmacología , Diseño de Fármacos , Disentería Bacilar/prevención & control , Shigella dysenteriae/efectos de los fármacos , Desarrollo de Vacunas/métodos , Vacunología/métodos , Animales , Antígenos Bacterianos/inmunología , Linfocitos B/efectos de los fármacos , Linfocitos B/inmunología , Linfocitos B/metabolismo , Linfocitos B/microbiología , Proteínas Bacterianas/inmunología , Vacunas Bacterianas/inmunología , Diseño Asistido por Computadora , Disentería Bacilar/inmunología , Disentería Bacilar/metabolismo , Disentería Bacilar/microbiología , Epítopos , Interacciones Huésped-Patógeno , Humanos , Simulación del Acoplamiento Molecular , Simulación de Dinámica Molecular , Farmacología en Red , Shigella dysenteriae/inmunología , Shigella dysenteriae/patogenicidad , Linfocitos T/efectos de los fármacos , Linfocitos T/inmunología , Linfocitos T/metabolismo , Linfocitos T/microbiología
3.
Protein Pept Lett ; 29(1): 46-56, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-34791999

RESUMEN

BACKGROUND: Porphyromonas gingivalis (P. gingivalis) is a pathogenic bacterium widely present in subgingival plaques of patients with periodontitis. It induces periodontitis with bone loss as its main feature by changing the number and composition of symbiotic microorganisms, as well as inducing the natural immune response of the host. However, the mechanism of the latter remains unclear. OBJECTIVE: This study aims to investigate the effect of P. gingivalis lipopolysaccharide (LPS) on regulatory B cells (Breg) in the occurrence and development of periodontitis. METHODS: We detected the mRNA levels of IL-10 in B cells under the stimulation of P. gingivalis LPS and/or E. coli LPS, distinguished IL-10-producing cells from different B cell subgroups using flow cytometry. Through toll-like receptor (TLR) knockout mice, the role of TLR2 and TLR4 in this process was also evaluated. RESULTS: Results showed that P. gingivalis stimulated B cells to produce IL-10 via TLR2/4. CD5+B1 subset is the main source of IL-10+Breg cell. Under P. gingivalis LPS stimulation, CD5+IgM+CD93-IL-10+B cell subset increased significantly, which was regulated through TLR2/ 4. CONCLUSION: The results of this study provides new insights into the immunopathogenic mechanism of P. gingivalis, preliminarily discussed the effect of P. gingivalis on the production of Breg, and present a theoretical foundation for subsequent investigations on the occurrence and development of periodontitis.


Asunto(s)
Linfocitos B , Porphyromonas gingivalis , Receptor Toll-Like 2 , Receptor Toll-Like 4 , Animales , Linfocitos B/citología , Linfocitos B/microbiología , Diferenciación Celular , Escherichia coli , Humanos , Lipopolisacáridos , Ratones , Ratones Noqueados , Receptor Toll-Like 2/genética , Receptor Toll-Like 4/genética
4.
Front Immunol ; 12: 698849, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34819929

RESUMEN

Candida albicans is usually a benign member of the human gut microbiota, but can become pathogenic under certain circumstances, for example in an immunocompromised host. The innate immune system, in particular neutrophils and macrophages, constitutes a crucial first line of defense against fungal invasion, however adaptive immunity may provide long term protection and thus allow vaccination of at risk patients. While TH1 and TH17 cells are important for antifungal responses, the role of B cells and antibodies in protection from C. albicans infection is less well defined. In this study, we show that C. albicans hyphae but not yeast, as well as fungal cell wall components, directly activate B cells via MyD88 signaling triggered by Toll- like receptor 2, leading to increased IgG1 production. While Dectin-1 signals and specific recognition by the B cell receptor are dispensable for B cell activation in this system, TLR2/MyD88 signals cooperate with CD40 signals in promoting B cell activation. Importantly, recognition of C. albicans via MyD88 signaling is also essential for induction of IL-6 secretion by B cells, which promotes TH17 polarization in T-B cell coculture experiments. B cells may thus be activated directly by C. albicans in its invasive form, leading to production of antibodies and T cell help for fungal clearance.


Asunto(s)
Linfocitos B/inmunología , Candida albicans/inmunología , Candidiasis/inmunología , Diferenciación Celular , Hifa/inmunología , Inmunoglobulina G/metabolismo , Interleucina-6/metabolismo , Células Th17/inmunología , Receptor Toll-Like 2/metabolismo , Animales , Linfocitos B/metabolismo , Linfocitos B/microbiología , Candida albicans/patogenicidad , Candidiasis/metabolismo , Candidiasis/microbiología , Células Cultivadas , Técnicas de Cocultivo , Interacciones Huésped-Patógeno , Humanos , Hifa/patogenicidad , Activación de Linfocitos , Ratones Endogámicos C57BL , Fenotipo , Vías Secretoras , Transducción de Señal , Células Th17/metabolismo , Células Th17/microbiología
5.
Front Immunol ; 12: 729607, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34804014

RESUMEN

The mucosal immune system is the first line of defense against pathogens. Germinal centers (GCs) in the Peyer's patches (PPs) of the small intestine are constantly generated through stimulation of the microbiota. In this study, we investigated the role of γδ T cells in the GC reactions in PPs. Most γδ T cells in PPs localized in the GCs and expressed a TCR composed of Vγ1 and Vδ6 chains. By using mice with partial and total γδ T cell deficiencies, we found that Vγ1+/Vδ6+ T cells can produce high amounts of IL-4, which drives the proliferation of GC B cells as well as the switch of GC B cells towards IgA. Therefore, we conclude that γδ T cells play a role in sustaining gut homeostasis and symbiosis via supporting the GC reactions in PPs.


Asunto(s)
Linfocitos B/metabolismo , Centro Germinal/metabolismo , Interleucina-4/metabolismo , Mucosa Intestinal/metabolismo , Linfocitos Intraepiteliales/metabolismo , Ganglios Linfáticos Agregados/metabolismo , Receptores de Antígenos de Linfocitos T gamma-delta/metabolismo , Animales , Linfocitos B/inmunología , Linfocitos B/microbiología , Diferenciación Celular , Proliferación Celular , Células Cultivadas , Modelos Animales de Enfermedad , Centro Germinal/inmunología , Centro Germinal/microbiología , Inmunidad Mucosa , Inmunoglobulina A/inmunología , Inmunoglobulina A/metabolismo , Cambio de Clase de Inmunoglobulina , Mucosa Intestinal/inmunología , Mucosa Intestinal/microbiología , Linfocitos Intraepiteliales/inmunología , Linfocitos Intraepiteliales/microbiología , Activación de Linfocitos , Depleción Linfocítica , Ratones Noqueados , Ganglios Linfáticos Agregados/inmunología , Ganglios Linfáticos Agregados/microbiología , Fenotipo , Receptores de Antígenos de Linfocitos T gamma-delta/genética , Receptores de Antígenos de Linfocitos T gamma-delta/inmunología , Infecciones por Salmonella/inmunología , Infecciones por Salmonella/metabolismo , Infecciones por Salmonella/microbiología , Salmonella typhimurium/inmunología , Salmonella typhimurium/patogenicidad , Transducción de Señal
6.
Front Immunol ; 12: 728685, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34659215

RESUMEN

Mucosal-associated invariant T (MAIT) cells are an innate-like population of T cells that display a TCR Vα7.2+ CD161+ phenotype and are restricted by the nonclassical MHC-related molecule 1 (MR1). Although B cells control MAIT cell development and function, little is known about the mechanisms underlying their interaction(s). Here, we report, for the first time, that during Salmonella enterica serovar Typhi (S. Typhi) infection, HLA-G expression on B cells downregulates IFN-γ production by MAIT cells. In contrast, blocking HLA-G expression on S. Typhi-infected B cells increases IFN-γ production by MAIT cells. After interacting with MAIT cells, kinetic studies show that B cells upregulate HLA-G expression and downregulate the inhibitory HLA-G receptor CD85j on MAIT cells resulting in their loss. These results provide a new role for HLA-G as a negative feedback loop by which B cells control MAIT cell responses to antigens.


Asunto(s)
Antígenos CD/metabolismo , Linfocitos B/metabolismo , Antígenos HLA-G/metabolismo , Receptor Leucocitario Tipo Inmunoglobulina B1/metabolismo , Células T Invariantes Asociadas a Mucosa/metabolismo , Salmonella typhi/patogenicidad , Fiebre Tifoidea/metabolismo , Adulto , Antígenos CD/genética , Linfocitos B/inmunología , Linfocitos B/microbiología , Células Cultivadas , Técnicas de Cocultivo , Femenino , Interacciones Huésped-Patógeno , Humanos , Interferón gamma/genética , Interferón gamma/metabolismo , Cinética , Receptor Leucocitario Tipo Inmunoglobulina B1/genética , Masculino , Persona de Mediana Edad , Células T Invariantes Asociadas a Mucosa/inmunología , Células T Invariantes Asociadas a Mucosa/microbiología , Fenotipo , Salmonella typhi/inmunología , Transducción de Señal , Fiebre Tifoidea/genética , Fiebre Tifoidea/inmunología , Fiebre Tifoidea/microbiología , Adulto Joven
7.
Gastroenterology ; 161(2): 522-535.e6, 2021 08.
Artículo en Inglés | MEDLINE | ID: mdl-33844987

RESUMEN

BACKGROUND AND AIMS: Crohn's disease and ulcerative colitis are characterized by dysregulated adaptive immune responses to the microbiota in genetically susceptible individuals, but the specificity of these responses remains largely undefined. Therefore, we developed a microbiota antigen microarray to characterize microbial antibody reactivity, particularly to human-derived microbiota flagellins, in inflammatory bowel disease. METHODS: Sera from healthy volunteers (n = 87) at the University of Alabama at Birmingham and from patients recruited from the Kirklin Clinic of University of Alabama at Birmingham Hospital, including patients with Crohn's disease (n = 152) and ulcerative colitis (n = 170), were individually probed against microbiota bacterial flagellins of both mouse and human origin and analyzed for IgG and IgA antibody responses. Circulating flagellin-reactive T effector (CD4+CD154+) and T regulatory (CD4+CD137+) cells were isolated and evaluated in selected patients. Resulting adaptive immune responses were compared with corresponding clinical data to determine relevancy to disease behavior. RESULTS: We show that patients with IBD express selective patterns of antibody reactivity to microbiota flagellins. Patients with Crohn's disease, but not patients with ulcerative colitis, display augmented serum IgG to human ileal-localized Lachnospiraceae flagellins, with a subset of patients having high responses to more than 10 flagellins. Elevated responses to CBir1, a mouse Lachnospiraceae flagellin used clinically to diagnose CD, correlated with multi-Lachnospiraceae flagellin reactivity. In this subset of patients with CD, multi-flagellin reactivity was associated with elevated flagellin-specific CD154+CD45RA- T memory cells, a reduced ratio of flagellin-reactive CD4+ T regulatory to T effector cells, and a high frequency of disease complications. CONCLUSIONS: Patients with Crohn's disease display strong adaptive immune response to human-derived Lachnospiraceae flagellins, which may be targeted for prognosis and future personalized therapies.


Asunto(s)
Inmunidad Adaptativa , Anticuerpos Antibacterianos/sangre , Antígenos Bacterianos/inmunología , Linfocitos T CD4-Positivos/inmunología , Clostridiales/inmunología , Enfermedad de Crohn/inmunología , Flagelina/inmunología , Inmunoglobulina G/sangre , Adulto , Anciano , Anciano de 80 o más Años , Antígenos Bacterianos/metabolismo , Linfocitos B/inmunología , Linfocitos B/metabolismo , Linfocitos B/microbiología , Linfocitos T CD4-Positivos/metabolismo , Linfocitos T CD4-Positivos/microbiología , Estudios de Casos y Controles , Clostridiales/metabolismo , Colitis Ulcerosa/sangre , Colitis Ulcerosa/inmunología , Colitis Ulcerosa/microbiología , Enfermedad de Crohn/sangre , Enfermedad de Crohn/microbiología , Estudios Transversales , Femenino , Flagelina/metabolismo , Humanos , Inmunoglobulina A/sangre , Masculino , Persona de Mediana Edad , Adulto Joven
8.
Front Immunol ; 12: 626627, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33746963

RESUMEN

Recent advances in complement research have revolutionized our understanding of its role in immune responses. The immunomodulatory features of complement in infections by intracellular pathogens, e.g., viruses, are attracting increasing attention. Thereby, local production and activation of complement by myeloid-derived cells seem to be crucial. We could recently show that C3, a key player of the complement cascade, is required for effective defense against the intracellular bacterium Chlamydia psittaci. Avian zoonotic strains of this pathogen cause life-threatening pneumonia with systemic spread in humans; closely related non-avian strains are responsible for less severe diseases of domestic animals with economic loss. To clarify how far myeloid- and non-myeloid cell-derived complement contributes to immune response and resulting protection against C. psittaci, adoptive bone marrow transfer experiments focusing on C3 were combined with challenge experiments using a non-avian (BSL 2) strain of this intracellular bacterium. Surprisingly, our data prove that for C. psittaci-induced pneumonia in mice, non-myeloid-derived, circulating/systemic C3 has a leading role in protection, in particular on the development of pathogen-specific T- and B- cell responses. In contrast, myeloid-derived and most likely locally produced C3 plays only a minor, mainly fine-tuning role. The work we present here describes authentic, although less pronounced, antigen directed immune responses.


Asunto(s)
Inmunidad Adaptativa , Infecciones por Chlamydia/microbiología , Chlamydophila psittaci/patogenicidad , Complemento C3/metabolismo , Pulmón/microbiología , Neumonía Bacteriana/microbiología , Traslado Adoptivo , Animales , Linfocitos B/inmunología , Linfocitos B/metabolismo , Linfocitos B/microbiología , Trasplante de Médula Ósea , Células Cultivadas , Infecciones por Chlamydia/inmunología , Infecciones por Chlamydia/metabolismo , Chlamydophila psittaci/inmunología , Complemento C3/genética , Modelos Animales de Enfermedad , Interacciones Huésped-Patógeno , Pulmón/inmunología , Pulmón/metabolismo , Masculino , Ratones Endogámicos C57BL , Ratones Noqueados , Neumonía Bacteriana/inmunología , Neumonía Bacteriana/metabolismo , Linfocitos T/inmunología , Linfocitos T/metabolismo , Linfocitos T/microbiología , Quimera por Trasplante
9.
Biochimie ; 182: 1-12, 2021 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-33412160

RESUMEN

The emergence of drug-resistant Mycobacterium tuberculosis (Mtb) stains has escalated the need for developing more efficient drugs and therapeutic strategies against tuberculosis. Here we functionally annotate a secretory mycobacterial asparaginase Rv1538c (MtA) and describe its biochemical properties. MtA primarily existed as dimer along with a minor population of multimers. Circular dichroism and fluorescence spectroscopy demonstrated a compact structure in Tris HCl buffer at pH 8.0. Under these conditions it also displayed optimum activity. It retained ∼40% activity at pH 5.5, supporting its physiological relevance in acidic phagosomal environment. MtA contravened classical Michaelis-Menten kinetics and exhibited product inhibition profile, yielding a Kcat of 869.4 s-1 and an apparent Km of 8.36 mM. We report the presence of several antigenic epitopes and a C-terminal YXXXD/E motif in MtA, hinting towards its potential to interact or influence host immune system. This was supported by our observation of morphological changes in MtA-treated human B lymphoblasts. We propose that MtA is a dual purpose enzyme used by Mtb to survive inside its host by; 1) ammonia-mediated neutralization of the phagosomal acidic pH and 2) inducing stress to primary immune cells and compromising the host immune response. Overall, this study contributes to our understanding of the biological role of mycobacterial asparaginase opening avenues for developing effective TB therapeutics.


Asunto(s)
Asparaginasa , Linfocitos B/microbiología , Proteínas Bacterianas , Viabilidad Microbiana , Mycobacterium tuberculosis , Fagosomas/microbiología , Asparaginasa/química , Asparaginasa/genética , Asparaginasa/metabolismo , Linfocitos B/metabolismo , Proteínas Bacterianas/química , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Humanos , Mycobacterium tuberculosis/enzimología , Mycobacterium tuberculosis/genética , Fagosomas/metabolismo , Células THP-1
10.
Front Immunol ; 12: 804244, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34975918

RESUMEN

Fc receptor (FcR) is an important opsonin receptor on the surface of immune cells, playing an important role in antibody-dependent cell-mediated immunity. Our previous work found that the FcR of flounder showed a marked expression response in phagocytizing IgM+ B cell, which suggested that FcR might participate in regulating Ig-opsonized phagocytosis. In this paper, in order to elucidate the potential role of FcR in mediating phagocytosis of IgM+ B cell, flounder anti-E. tarda serum was prepared and complement-inactivated for the use of E. tarda opsonization, and the sera of healthy flounder were used as control. Flow cytometric analysis showed that the phagocytosis rates of antiserum-opsonized E. tarda in peripheral blood mIgM+ B lymphocytes were significantly higher than the control group, and higher phagocytosis rates of mIgM+ B lymphocyte could be detected with an increasing incubation time ranging from 1 to 5 h. The phagocytosis rates of antiserum-opsonized E. tarda by mIgM+ B lymphocyte for an incubation time of 1, 3 or 5 h were 51.1, 63.0, and 77.5% respectively, which were significantly higher than the phagocytosis rates in the control groups with 40.2, 50.9, and 63.8%, respectively. While the Fc fragment of IgM on the surface of opsonized E. tarda was blocked by rabbit anti-flounder IgM polyclonal antibodies, phagocytosis rates of mIgM+ B lymphocyte decreased significantly compared with the unblocked group. Moreover, the proportion of mIgM+ B lymphocytes with higher intracellular reactive oxygen species (ROS) levels rose to 32.1% from the control level of 23.0% after phagocytosis of antiserum-opsonized E. tarda. FcγRII and Syk were found to be significantly upregulated, while FcγRIII was significantly downregulated in the mIgM+ B lymphocytes post phagocytosis. Furthermore, when FcγRII of mIgM+ B lymphocytes was blocked by the prepared antibodies, their phagocytosis rate of antiserum-opsonized E. tarda was 39.0%, which was significantly lower than the unblocked group of 54.0%. These results demonstrate that FcR plays a critical role in mediating phagocytosis and bactericidal activity of mIgM+ B lymphocytes, which would facilitate an improved understanding of the regulatory roles of FcR in phagocytosis of teleost B lymphocytes.


Asunto(s)
Linfocitos B/metabolismo , Edwardsiella tarda/patogenicidad , Infecciones por Enterobacteriaceae/metabolismo , Proteínas de Peces/metabolismo , Lenguado/metabolismo , Inmunoglobulina M/metabolismo , Opsonización , Receptores Fc/metabolismo , Animales , Linfocitos B/inmunología , Linfocitos B/microbiología , Células Cultivadas , Edwardsiella tarda/inmunología , Infecciones por Enterobacteriaceae/inmunología , Proteínas de Peces/genética , Proteínas de Peces/inmunología , Lenguado/genética , Lenguado/inmunología , Lenguado/microbiología , Regulación de la Expresión Génica , Interacciones Huésped-Patógeno , Inmunidad Innata , Inmunoglobulina M/genética , Inmunoglobulina M/inmunología , Receptores Fc/genética , Receptores Fc/inmunología , Transducción de Señal , Factores de Tiempo
11.
Front Immunol ; 12: 776913, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-35069548

RESUMEN

Non-human primate models of Tuberculosis (TB) are one of the most commonly used within the experimental TB field because they closely mimic the whole spectrum of disease progression of human TB. However, the early cellular interactions of the pulmonary granuloma are still not well understood. The use of this model allows investigation into the early interactions of cells within pulmonary granulomas which cannot be undertaken in human samples. Pulmonary granulomas from rhesus and cynomolgus macaques from two timepoints post infection were categorised into categories 1 - 6 (early to late stage granulomas) and immunohistochemistry was used to identify CD68+ macrophages, CD3+ T cells and CD20+ B cells. Multinucleated giant cells and acid-fast bacilli were also quantified. At week four post infection, cynomolgus macaques were found to have more CD68+ cells than rhesus in all but category 1 granulomas. Cynomolgus also had a significantly higher percentage of CD20+ B cells in category 1 granulomas. At week twelve post infection, CD68+ cells were most abundant in category 4 and 5 granulomas in both species; however, there were no significant differences between them. CD3+ T cells and CD20+ B cells were significantly higher in the majority of granuloma categories in cynomolgus compared to rhesus. Multinucleated giant cells and acid-fast bacilli were most abundant in categories 5 and 6 at week 12 post challenge in both species. This study has identified the basic cellular composition and spatial distribution of immune cells within pulmonary granulomas in both rhesus and cynomolgus macaques over time. The data from this study will add to the knowledge already gained in this field and may inform future research on vaccines and therapeutics for TB.


Asunto(s)
Linfocitos B , Linfocitos T CD8-positivos , Granuloma , Macrófagos , Mycobacterium tuberculosis/inmunología , Tuberculosis Pulmonar , Animales , Linfocitos B/inmunología , Linfocitos B/microbiología , Linfocitos B/patología , Linfocitos T CD8-positivos/inmunología , Linfocitos T CD8-positivos/microbiología , Linfocitos T CD8-positivos/patología , Modelos Animales de Enfermedad , Granuloma/inmunología , Granuloma/microbiología , Granuloma/patología , Macaca fascicularis , Macaca mulatta , Macrófagos/inmunología , Macrófagos/microbiología , Macrófagos/patología , Tuberculosis Pulmonar/inmunología , Tuberculosis Pulmonar/microbiología , Tuberculosis Pulmonar/patología
12.
J Pathol ; 253(1): 1-10, 2021 01.
Artículo en Inglés | MEDLINE | ID: mdl-33044742

RESUMEN

Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) was suggested as an entity separate from other types of Hodgkin lymphoma 40 years ago and recognized in the WHO classification in 2001. Based on its relatively benign course with late distant relapses, relation with lymph node hyperplasia with progressively transformed germinal centers, presence of clonal immunoglobulin gene rearrangements with somatic hypermutations and ongoing mutations, and relation with a number of inherited defects affecting the immune system, it has been suspected that NLPHL might be antigen-driven. Recent evidence has shown that cases of IgD-positive NLPHL are associated with infection by Moraxella catarrhalis, a common bacterium in the upper respiratory tract and in lymph nodes. This review summarizes the evidence for NLPHL as a B-cell lymphoma involving follicular T-lymphocytes normally found in germinal centers, its molecular features and relation to inherited immune defects, and its relation and differential diagnosis from similar entities. Finally, it discusses the evidence that in many cases a watch and wait policy might be a viable initial management strategy. © 2020 The Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.


Asunto(s)
Antígenos de Neoplasias/inmunología , Linfocitos B/inmunología , Enfermedad de Hodgkin/inmunología , Moraxella catarrhalis/inmunología , Infecciones por Moraxellaceae/inmunología , Linfocitos T/inmunología , Antígenos de Neoplasias/genética , Linfocitos B/microbiología , Enfermedad de Hodgkin/genética , Enfermedad de Hodgkin/microbiología , Enfermedad de Hodgkin/terapia , Humanos , Moraxella catarrhalis/patogenicidad , Infecciones por Moraxellaceae/microbiología , Fenotipo , Pronóstico , Linfocitos T/microbiología , Microambiente Tumoral
13.
PLoS One ; 15(10): e0240626, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33045031

RESUMEN

Mycoplasma genitalium is a sexually transmitted bacterial pathogen that infects men and women. Antigenic variation of MgpB and MgpC, the immunodominant adherence proteins of M. genitalium, is thought to contribute to immune evasion and chronic infection. We investigated the evolution of mgpB and mgpC sequences in men with non-gonococcal urethritis persistently infected with M. genitalium, including two men with anti-M. genitalium antibodies at enrollment and two that developed antibodies during follow-up. Each of the four patients was persistently infected with a different strain type and each patient produced antibodies targeting MgpB and MgpC. Amino acid sequence evolution in the variable regions of MgpB and MgpC occurred in all four patients with changes observed in single and multiple variable regions over time. Using the available crystal structure of MgpC of the G37 type strain we found that predicted conformational B cell epitopes localize predominantly to the variable region of MgpC, amino acids that changed during patient infection lie in these epitopes, and variant amino acids are in close proximity to the conserved sialic acid binding pocket. These findings support the hypothesis that sequence variation functions to avoid specific antibodies thereby contributing to persistence in the genital tract.


Asunto(s)
Adhesinas Bacterianas/genética , Infecciones por Mycoplasma/genética , Mycoplasma genitalium/genética , Uretritis/genética , Secuencia de Aminoácidos/genética , Animales , Anticuerpos Antiidiotipos/sangre , Anticuerpos Antiidiotipos/inmunología , Linfocitos B/inmunología , Linfocitos B/microbiología , Chlorocebus aethiops , Doxiciclina/farmacología , Evolución Molecular , Humanos , Infecciones por Mycoplasma/sangre , Infecciones por Mycoplasma/inmunología , Infecciones por Mycoplasma/microbiología , Mycoplasma genitalium/inmunología , Mycoplasma genitalium/patogenicidad , Reacción en Cadena de la Polimerasa , Uretritis/sangre , Uretritis/inmunología , Uretritis/microbiología , Células Vero
14.
Bull Exp Biol Med ; 169(4): 483-485, 2020 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-32910379

RESUMEN

We studied the expression of activation markers CD25 and CD69 by blood lymphocytes in white mice vaccinated with Brucella abortus 19 BA in antigen-specific tests in vitro. During incubation of blood lymphocytes with brucellosis polysaccharide-protein antigen, a statistically significant increase in the expression of CD25 by B cells and CD69 by T cells was observed; brucellin increased the expression of CD25 by B and T cells. Comparative analysis of the action of antigen preparations B. abortus showed that only brucellin has antigen-specific activity against CD19+CD25+ cells. The used method can be considered as a promising test for evaluation of the effectiveness of brucellosis immunoprophylaxis, which substantiates the need for further research.


Asunto(s)
Antígenos Bacterianos/administración & dosificación , Linfocitos B/efectos de los fármacos , Brucella abortus/inmunología , Brucelosis/inmunología , Linfocitos T/efectos de los fármacos , Animales , Antígenos Bacterianos/inmunología , Antígenos CD/genética , Antígenos CD/inmunología , Antígenos de Diferenciación de Linfocitos T/genética , Antígenos de Diferenciación de Linfocitos T/inmunología , Linfocitos B/inmunología , Linfocitos B/microbiología , Brucelosis/diagnóstico , Brucelosis/microbiología , Femenino , Citometría de Flujo , Expresión Génica , Inmunofenotipificación , Subunidad alfa del Receptor de Interleucina-2/genética , Subunidad alfa del Receptor de Interleucina-2/inmunología , Lectinas Tipo C/genética , Lectinas Tipo C/inmunología , Activación de Linfocitos/efectos de los fármacos , Ratones , Linfocitos T/inmunología , Linfocitos T/microbiología , Vacunación
15.
Biochem Biophys Res Commun ; 533(3): 282-288, 2020 12 10.
Artículo en Inglés | MEDLINE | ID: mdl-32958255

RESUMEN

Dendritic cells (DC) are the most important antigen-presenting cells, which guide T cell activation and function, and dysregulated DC function might be one of the crucial causes of inflammatory bowel disease (IBD). It has been well-known that microbiota and their metabolites play an essential role in regulating the biology and function of DC, thus contributing to the pathogenesis of IBD. However, the underlying mechanisms remain largely unknown. Amphiregulin (AREG), a molecule of the epidermal growth factor (EGF) family, is primarily described as an epithelial cell-derived cytokine and recognized as a critical regulator of cell proliferation and tissue repair. Here, we found that DC expression of AREG depended on butyrate (a microbiota-derived short chained fatty acid), which required the interaction between butyrate and G-protein-coupled receptor 43 (GPR43). Furthermore, we found that butyrate-GPR43 interaction failed to induce AREG expression in DC deficient in B lymphocyte induced maturation protein 1 (Blimp-1). Notably, DC-derived AREG was indispensable for the protection against experimental colitis in mice. Additionally, AREG expression was significantly decreased in DC from IBD patients. Our data provide novel evidences to interpret how AREG expression is regulated in DC, and shed new light on the mechanisms whereby microbiota regulate DC function.


Asunto(s)
Anfirregulina/genética , Butiratos/inmunología , Colitis Ulcerosa/genética , Enfermedad de Crohn/genética , Células Dendríticas/inmunología , Factor 1 de Unión al Dominio 1 de Regulación Positiva/genética , Receptores de Superficie Celular/genética , Anfirregulina/inmunología , Animales , Linfocitos B/inmunología , Linfocitos B/microbiología , Linfocitos B/patología , Butiratos/metabolismo , Butiratos/farmacología , Estudios de Casos y Controles , Colitis Ulcerosa/inducido químicamente , Colitis Ulcerosa/inmunología , Colitis Ulcerosa/microbiología , Enfermedad de Crohn/inmunología , Enfermedad de Crohn/microbiología , Enfermedad de Crohn/patología , Células Dendríticas/microbiología , Células Dendríticas/patología , Femenino , Microbioma Gastrointestinal/inmunología , Regulación de la Expresión Génica , Humanos , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Proteínas Asociadas a Pancreatitis/deficiencia , Proteínas Asociadas a Pancreatitis/genética , Proteínas Asociadas a Pancreatitis/inmunología , Factor 1 de Unión al Dominio 1 de Regulación Positiva/inmunología , Receptores de Superficie Celular/inmunología , Receptores Acoplados a Proteínas G/deficiencia , Receptores Acoplados a Proteínas G/genética , Receptores Acoplados a Proteínas G/inmunología , Transducción de Señal , Dodecil Sulfato de Sodio/administración & dosificación , Proteína de la Zonula Occludens-1/genética , Proteína de la Zonula Occludens-1/inmunología
16.
Front Immunol ; 11: 1946, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32903485

RESUMEN

Recent studies have demonstrated that induction of a diverse repertoire of memory T cells ("immune education") affects responses to murine cecal ligation and puncture (CLP), the most widely - used animal model of sepsis. Among the documented effects of immune education on CLP are changes in T cell, macrophage and neutrophil activity, more pronounced organ dysfunction and reduced survival. Little is known, however, about the effects of CLP on B cell responses, and how these responses might be altered by immune education. Importantly, effective B cell responses are modulated by IL21 produced by CD4+/CXCR5+/PD1+ T follicular helper (Tfh) cells. We examined the B cell population in control and immune educated mice 24 h and 60 days after CLP. Education alone increased Tfh cells. Twenty-four hours after CLP, Tfh cells were depleted. However, this reduction was less pronounced in immune educated mice than in controls and the percentage of CD4 T cells expressing a Tfh phenotype increased in the animals. CLP did not alter splenic architecture and decreased numbers of follicular, marginal, and germinal center B cells. CLP induced changes were not, however, noted following CLP in immune educated mice. At 60 days post - CLP, numbers of follicular, germinal center and marginal zone B cells were increased; this increase was more pronounced in immune educated mice. Finally, while CLP reduced the induction of antigen specific B cells in controls, this response was maintained following CLP in immune educated mice. Our data suggest that preexisting Tfh assists in rescuing the B cell response to CLP.


Asunto(s)
Linfocitos B/inmunología , Bacterias/inmunología , Ciego/microbiología , Sepsis/inmunología , Células T Auxiliares Foliculares/inmunología , Animales , Linfocitos B/metabolismo , Linfocitos B/microbiología , Bacterias/patogenicidad , Ciego/cirugía , Proliferación Celular , Citocinas/inmunología , Citocinas/metabolismo , Modelos Animales de Enfermedad , Interacciones Huésped-Patógeno , Inmunidad Innata , Memoria Inmunológica , Ligadura , Activación de Linfocitos , Masculino , Ratones Endogámicos C57BL , Fenotipo , Punciones , Sepsis/metabolismo , Sepsis/microbiología , Células T Auxiliares Foliculares/metabolismo , Células T Auxiliares Foliculares/microbiología , Factores de Tiempo
17.
Eur J Pharmacol ; 884: 173421, 2020 Oct 05.
Artículo en Inglés | MEDLINE | ID: mdl-32721450

RESUMEN

Emerging evidences indicated that the dysbiosis of microbiota was related to the onset of systemic lupus erythematosus (SLE). Bacteroides fragilis (B. fragilis) ATCC 25285, a human commensal, was discovered to improve inflammatory diseases. However, whether B. fragilis (ATCC 25285) has the beneficial effects on the treatment of lupus nephritis has still remained elusive. In the present study, oral treatment with B. fragilis (ATCC 25285) ameliorated the activity of MRL/lpr mice, including decreased levels of autoantibodies and symptoms of lupus nephritis. Furthermore, we demonstrated that treatment with B. fragilis (ATCC 25285) could promote CD1d expression in B cells by Est-1 pathway, while inhibit CD86 expression via SHP-2 signaling pathway to repair the immune response of B cells in MRL/lpr mice. In addition, our findings revealed a possible role of treatment with B. fragilis (ATCC 25285) in relieving intestinal inflammation in MRL/lpr mice. Meanwhile, it was uncovered that B. fragilis (ATCC 25285) restored the Th17/Treg balance in MRL/lpr mice that was consistent with the role of B. fragilis in other autoimmune diseases. Overall, the current study may highlight the potential application of B. fragilis (ATCC 25285) to treat manifestations of SLE in high-risk individuals.


Asunto(s)
Antígenos CD1d/metabolismo , Linfocitos B/microbiología , Antígeno B7-2/metabolismo , Bacteroides fragilis/fisiología , Nefritis Lúpica/terapia , Probióticos , Animales , Antígenos CD1d/inmunología , Autoanticuerpos/sangre , Linfocitos B/inmunología , Linfocitos B/metabolismo , Antígeno B7-2/inmunología , Modelos Animales de Enfermedad , Femenino , Nefritis Lúpica/inmunología , Nefritis Lúpica/metabolismo , Nefritis Lúpica/microbiología , Ratones Endogámicos C57BL , Ratones Endogámicos MRL lpr , Proteína Tirosina Fosfatasa no Receptora Tipo 11/metabolismo , Proteína Proto-Oncogénica c-ets-1/metabolismo , Transducción de Señal , Linfocitos T Reguladores/inmunología , Linfocitos T Reguladores/metabolismo , Linfocitos T Reguladores/microbiología , Células Th17/inmunología , Células Th17/metabolismo , Células Th17/microbiología
18.
JCI Insight ; 5(16)2020 08 20.
Artículo en Inglés | MEDLINE | ID: mdl-32663199

RESUMEN

Clostridioides difficile is a leading cause of nosocomial infection responsible for significant morbidity and mortality with limited options for therapy. Secreted C. difficile toxin B (TcdB) is a major contributor to disease pathology, and select TcdB-specific Abs may protect against disease recurrence. However, the high frequency of recurrence suggests that the memory B cell response, essential for new Ab production following C. difficile reexposure, is insufficient. We therefore isolated TcdB-specific memory B cells from individuals with a history of C. difficile infection and performed single-cell deep sequencing of their Ab genes. Herein, we report that TcdB-specific memory B cell-encoded antibodies showed somatic hypermutation but displayed limited isotype class switch. Memory B cell-encoded mAb generated from the gene sequences revealed low to moderate affinity for TcdB and a limited ability to neutralize TcdB. These findings indicate that memory B cells are an important factor in C. difficile disease recurrence.


Asunto(s)
Anticuerpos Neutralizantes/inmunología , Linfocitos B/inmunología , Proteínas Bacterianas/inmunología , Toxinas Bacterianas/inmunología , Infecciones por Clostridium/inmunología , Adulto , Anciano , Anciano de 80 o más Años , Animales , Anticuerpos Monoclonales/inmunología , Anticuerpos Monoclonales/metabolismo , Linfocitos B/microbiología , Células CHO , Estudios de Casos y Controles , Clostridioides difficile/inmunología , Cricetulus , Humanos , Inmunoglobulina G/genética , Inmunoglobulina G/inmunología , Memoria Inmunológica , Persona de Mediana Edad , Hipermutación Somática de Inmunoglobulina
19.
Infect Immun ; 88(8)2020 07 21.
Artículo en Inglés | MEDLINE | ID: mdl-32423914

RESUMEN

Chlamydia bacteria are obligate intracellular pathogens which can cause a variety of disease in humans and other vertebrate animals. To successfully complete its life cycle, Chlamydia must evade both intracellular innate immune responses and adaptive cytotoxic T cell responses. Here, we report on the role of the chlamydial lipooligosaccharide (LOS) in evading the immune response. Chlamydia infection is known to block the induction of apoptosis. However, when LOS synthesis was inhibited during Chlamydia trachomatis infection, HeLa cells regained susceptibility to apoptosis induction following staurosporine treatment. Additionally, the delivery of purified LOS to the cytosol of cells increased the levels of the antiapoptotic protein survivin. An increase in survivin levels was also detected following C. trachomatis infection, which was reversed by blocking LOS synthesis. Interestingly, while intracellular delivery of lipopolysaccharide (LPS) derived from Escherichia coli was toxic to cells, LOS from C. trachomatis did not induce any appreciable cell death, suggesting that it does not activate pyroptosis. Chlamydial LOS was also a poor stimulator of maturation of bone marrow-derived dendritic cells compared to E. coli LPS. Previous work from our group indicated that LOS synthesis during infection was necessary to alter host cell antigen presentation. However, direct delivery of LOS to cells in the absence of infection did not alter antigenic peptide presentation. Taken together, these data suggest that chlamydial LOS, which is remarkably conserved across the genus Chlamydia, may act both directly and indirectly to allow the pathogen to evade the innate and adaptive immune responses of the host.


Asunto(s)
Inmunidad Adaptativa/efectos de los fármacos , Infecciones por Chlamydia/inmunología , Chlamydia trachomatis/inmunología , Evasión Inmune , Inmunidad Innata/efectos de los fármacos , Lipopolisacáridos/farmacología , Animales , Apoptosis/efectos de los fármacos , Apoptosis/inmunología , Linfocitos B/efectos de los fármacos , Linfocitos B/inmunología , Linfocitos B/microbiología , Células de la Médula Ósea/citología , Células de la Médula Ósea/efectos de los fármacos , Células de la Médula Ósea/inmunología , Línea Celular Transformada , Infecciones por Chlamydia/genética , Infecciones por Chlamydia/microbiología , Infecciones por Chlamydia/patología , Chlamydia trachomatis/patogenicidad , Células Dendríticas/citología , Células Dendríticas/efectos de los fármacos , Células Dendríticas/inmunología , Inhibidores Enzimáticos/farmacología , Escherichia coli/química , Expresión Génica , Células HeLa , Humanos , Lipopolisacáridos/inmunología , Ratones Endogámicos C57BL , Ratones Transgénicos , Especificidad de la Especie , Estaurosporina/farmacología , Survivin/genética , Survivin/inmunología
20.
Am J Med Sci ; 359(6): 347-353, 2020 06.
Artículo en Inglés | MEDLINE | ID: mdl-32354596

RESUMEN

BACKGROUND: CD19+IL-10+B cells are considered as a particular subset of immunosuppressive cells by producing interleukin 10 (IL-10), which plays an important role in infectious and autoimmune diseases. The aim of this study was to determine the number of CD19+IL-10+B cells in Helicobacter pylori (H. pylori) positive patients in comparison with H. pylori negative patients, and to determine the association with different clinical outcomes, such as gastritis and peptic ulcer disease (PUD), in infected patients. METHODS AND MATERIALS: We studied 25 infected patients with gastritis, 25 infected patients with PUD, and 25 patients negative for H. pylori. The number of CD19+IL-10+B cells was determined by immunofluorescence. RESULTS: The number of CD19+IL-10+B cells in patients infected with H. pylori was significantly 2.5-fold higher than uninfected patients (P < 0.0001). Also, the number of CD19+IL-10+B cells in infected patients with gastritis was significantly 1.45-fold elevated compared to infected patients with PUD (P = 0.001). CONCLUSIONS: These results demonstrate that the increased number of CD19+IL-10+B cells in infected patients and its association with other cells may play an important role in the pathogenesis of H. pylori infection.


Asunto(s)
Antígenos CD19/metabolismo , Linfocitos B/microbiología , Mucosa Gástrica/metabolismo , Infecciones por Helicobacter/inmunología , Interleucina-10/metabolismo , Adulto , Anciano , Femenino , Mucosa Gástrica/microbiología , Gastritis/sangre , Gastritis/microbiología , Helicobacter pylori , Humanos , Masculino , Microscopía Fluorescente , Persona de Mediana Edad , Úlcera Péptica/sangre , Úlcera Péptica/microbiología , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA